freestyle libre flash glucose monitoring system.

#FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM. PDF#
#FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM. PATCH#
#FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM. TRIAL#

#FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM. TRIAL#

These data are in accordance with those previously reported in the IMPACT trial which showed in 328 well-controlled individuals with type 1 diabetes that the time spent in nocturnal hypoglycaemia and the number of serious hypoglycaemia (<55 mg/dL) were significantly reduced among individuals wearing the device. “Real-world” data looking at more than 400 million individual glucose measurements recently reported that the best HbA1c values and time in range (between 70 mg/dL and 180 ml/dL) were observed among users performing the highest number of scans per day. 8- 10 As they provide reliable information about glucose control and variability, incidence, depth and duration of hypoglycaemic events, AGP-generated graphs can be easily used by the patient, either alone or with health care professionals (HCP) as an educational tool.

#FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM. PDF#

Data can be uploaded from the reader through a software (Ambulatory Glucose profile, ) that generates standardized glucose summaries stored as PDF files. The reader displays the actual glucose value, a trend arrow (based on the last 15-minute glucose levels) which gives information on rate and direction of glucose changes, and retrospective glucose readings over the last 8 hours. Real-time glucose values are visualized on demand by transfer from the sensor, as soon as it is brought in close vicinity of the sensor.

5- 7 Interstitial fluid glucose levels are measured every minute, recorded every 15 minutes and stored for a period of 90 days.

#FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM. PATCH#

In contrast to CGM systems, FGM is based on the use of low cost, factory-calibrated 14-day small size patch glucose sensors with MARD close to 10%. 4 FSL continuously measures interstitial fluid glucose levels in real time. 4 An alternative technology, the FreeStyle Libre (FSL) glucose monitoring (FGM), recently made available by Abbott Diabetes Care, overcome these pitfalls. 3įew major problems though still hamper the use of CGM for glucose management on a large scale, that is, the need of daily finger-stick BGM for device calibration, the short sensor lifetime and the price.

The recent availability of devices with MARD (mean absolute relative difference) below 10% compared with capillary blood glucose monitoring (BGM) allows CGM-derived glucose values of being used for self-adjustment of insulin dosages without adjuvant use of BGM. 1, 2 Ongoing improvements, since early 2000, have been brought in terms of safety, user acceptance and accuracy. Nowadays, real-time continuous glucose monitoring (CGM) is increasingly used for diabetes management. The new FGM system facilitates the therapeutic empowerment of people with T1D, but in a context of structured education. Our study shows that using the FGM system improves HbA1c levels in people with T1D along with a moderate increase in the number of mild hypoglycaemic events. They were correlated with improved HbA1c. The number (but not the duration) of hypoglycaemic events slightly increased from 16.9 ± 1.44 per month at baseline to 24.0 ± 2.91 per month at 12 months, after reaching a peak of 26.4 ± 2.31 per month at 6 months. HbA1c levels decreased from 8.51% ± 0.14% at baseline to 7.77% ± 0.09% after 3 months to slightly increase to 7.92% ± 0.09% at 12 months, in correlation with the number of scans per day. Participants stopped immediately of measuring capillary blood glucose (2.88 ± 0.12 per day) (mean ± SEM) after having received the first FSL device and the number of scans per day increased up to 8.87 ± 0.58 per day. After having been instructed about FGM utilization, participants were trained to optimize the glycaemic control. This 12-month observational study included 120 individuals with T1D evaluated every 3 months. We sought of evaluating the tolerance, the acceptance and the efficacy of the FGM system in routine medical practice. There are not yet data reporting the impact of FGM in people with T1D in real-life conditions. Using the novel FreeStyle Libre (FSL), glucose monitoring (FGM) system becomes increasingly popular among people with type 1 diabetes (T1D) and is associated with less and shorter hypoglycaemic events without deterioration of HbA1c.

Freestyle libre flash glucose monitoring system.